Zadik–Barak–Levin syndrome
| Zadik–Barak–Levin syndrome | |
|---|---|
| Synonyms | ZBLS |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Short stature, microcephaly, developmental delay, dysmorphic features |
| Complications | N/A |
| Onset | Congenital |
| Duration | Lifelong |
| Types | N/A |
| Causes | Genetic mutation |
| Risks | Family history |
| Diagnosis | Clinical evaluation, genetic testing |
| Differential diagnosis | Other genetic syndromes |
| Prevention | N/A |
| Treatment | Supportive care, symptomatic treatment |
| Medication | N/A |
| Prognosis | Variable |
| Frequency | Rare |
| Deaths | N/A |
Zadik–Barak–Levin syndrome (ZBLS) is a rare congenital disorder that manifests in humans. This syndrome presents a spectrum of abnormalities primarily rooted in embryonic development, particularly affecting the mesodermal-ectodermal midline. The key features of this disorder include primary hypothyroidism, cleft palate, hypodontia, and characteristics of ectodermal dysplasia.
Etiology and Pathogenesis[edit]
ZBLS arises from embryonic disruptions during the formation phase of the mesodermal-ectodermal midline. This disruption is considered pivotal in the syndrome's etiology, though the exact molecular mechanisms remain under investigation[1].
Signs and Symptoms[edit]
Patients diagnosed with ZBLS may exhibit a range of the following clinical features:
- Anodontia or oligodontia, characterized by a complete absence or significantly fewer teeth than normal.
- Presence of a cleft palate.
- Depressed nasal bridge.
- Dry skin, typical of ectodermal dysplasia.
- Ectopic, absent (agenesis), or underdeveloped (hypoplastic) thyroid gland.
- Presence of epibulbar dermoid.
- Frontal bossing or pronounced forehead.
- Hypertelorism - Increased distance between the eyes.
- Clinical hypothyroidism.
- Spinal curvature (lordosis).
- Enlarged tongue (macroglossia).
- Abnormally small head circumference (microcephaly).
- A notably small (micrognatia) or recessed (retrognatia) jaw.
- Excess amniotic fluid during pregnancy (polyhydramnios).
- Disproportionately short stature or dwarfism.
- Sparse to absent scalp hair.
- Eye abnormalities including squint or paresis of ocular muscles.
- Protrusion of the navel (umbilical hernia).
Diagnosis[edit]
The diagnosis of ZBLS is primarily based on clinical examination and symptom presentation. Radiographic imaging and genetic testing may also aid in the diagnosis and differentiation from other syndromes with overlapping symptoms[2].
Management[edit]
Management strategies for ZBLS are multifaceted and often involve a multidisciplinary approach, catering to the specific needs and symptoms of each individual patient. Therapeutic measures may include hormone replacement for hypothyroidism, dental interventions for dental anomalies, and surgical corrections for structural abnormalities like cleft palate[3].
References[edit]
- ↑ Pinhas-Hamiel O, Zadik Z, Filmar S, Zaharan Y, Levy J, Rakover Y. "Congenital hypothyroidism, spiky hair, cleft palate, bifid uvula, hypospadias and bronchial stenosis: a new form of syndromic hypothyroidism." Journal of Pediatric Endocrinology and Metabolism. 2009;22(5):467-73.
- ↑ Aldred MA, Sanford RO, Thomas NS, Barrow MA, Wilson LC. "A new autosomal dominant syndrome of cleft palate, dental anomalies, and ectodermal dysplasia in a three-generation family." Journal of Medical Genetics. 1992;29(12):886-90.
- ↑ Priolo M, Lerone M, Rosaia L, Zerega G, Ravazzolo R, Silengo M. "A new syndrome with hypohidrosis and dryness of the skin, hyperthermia, unusual facial appearance, and dental anomalies." American Journal of Medical Genetics. 2000;90(1):61-6.
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian